Related Experiment Video
Updated: Nov 5, 2025

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case-Control and
Jing Li1, Yanqun Zhang1, Xue Guo1
1Department of Health Care, Jinan People's Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, 271100, People's Republic of China.
Insights
Elevated monocyte chemoattractant protein-1 (MCP1) levels are linked to a higher risk of coronary artery disease (CAD). This finding suggests MCP1 may play a role in the development of this leading cause of death.
Area of Science:
- Cardiovascular Research
- Immunology
- Genetics
Background:
- Coronary artery disease (CAD) is a leading global cause of mortality.
- Inflammation is recognized as a key factor in all stages of CAD and atherogenesis.
- Monocyte chemoattractant protein-1 (MCP1) is a critical regulator of monocyte migration.
Purpose of the Study:
- To investigate the association between CAD risk and genetic predisposition to circulating MCP1 levels.
- To explore the role of MCP1 in the pathophysiology of coronary artery disease.
Main Methods:
- A case-control study was conducted to assess the relationship between MCP1 levels and CAD risk.
- A two-sample Mendelian randomization (MR) study was employed to examine the causal effect of genetically predicted MCP1 levels on CAD risk.
- Sensitivity analyses, including MR Egger intercept tests, were performed to ensure the robustness of the findings and assess pleiotropy.
Main Results:
- The case-control study revealed a significant association between higher circulating MCP1 levels and increased CAD risk (OR per quartile: 1.33).
- Mendelian randomization analysis indicated that genetically predicted higher MCP1 levels were significantly associated with a higher risk of CAD (OR per 1-SD increase: 1.05).
- Sensitivity analyses confirmed the main findings and found no evidence of directional pleiotropy.
Conclusions:
- The study suggests a significant association between an increased predisposition to higher MCP1 levels and elevated risk of coronary artery disease.
- Further research is warranted to fully elucidate the contribution of MCP1 to the pathogenesis of CAD.
Background:
Coronary artery disease (CAD) ranks the leading cause of death worldwide, and inflammation has been implicated in all stages of CAD and is considered to contribute to the pathophysiological basis of atherogenesis.
Methods:
Here, we implemented a case-control study and a two-sample Mendelian randomization (MR) study to explore the associations between CAD risk and genetic predisposition to circulating level of monocyte chemoattractant protein-1 (MCP1), the most important regulator of monocyte trafficking.
Results:
In case-control study, we found circulating level of MCP1 was significantly associated with increased risk of CAD (OR for per quartile increment: 1.33, 95% CI: 1.19-1.49, P<0.001). Further, genetically predicted higher level of MCP1 was significantly associated with higher risk of CAD (OR for 1-SD increase: 1.05, 95% CIs: 1.02-1.08, P value: 0.002) in MR analysis. Sensitivity analyses were also conducted to validate the main findings, and we also did not detect any directional pleiotropy effects using the MR Egger intercept test (P=0.831).
Conclusion:
To sum up, our study suggested that increased CAD risk was associated with a predisposition to higher level of MCP1. Additional insight into the contribution of MCP1 to the occurrence of CAD is still needed.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...